Kallikrein 11 Antibody (371604) Summary
Immunogen |
Mouse myeloma cell line NS0-derived recombinant human Kallikrein 11
Glu51-Asn282 Accession # Q9UBX7 |
Specificity |
Detects human Kallikrein 11 in direct ELISAs.
|
Source |
N/A
|
Isotype |
IgG2a
|
Clonality |
Monoclonal
|
Host |
Rat
|
Gene |
KLK11
|
Purity |
Protein A or G purified from hybridoma culture supernatant
|
Innovators Reward |
Test in a species/application not listed above to receive a full credit towards a future purchase.
Learn about the Innovators Reward
|
Applications/Dilutions
Dilutions |
|
Packaging, Storage & Formulations
Storage |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Buffer |
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 µm filtered solution in PBS.
|
Preservative |
No Preservative
|
Concentration |
LYOPH
|
Purity |
Protein A or G purified from hybridoma culture supernatant
|
Reconstitution Instructions |
Reconstitute at 0.5 mg/mL in sterile PBS.
|
Notes
Alternate Names for Kallikrein 11 Antibody (371604)
- EC 3.4.21
- EC 3.4.21.-
- EC 3.4.21.4
- Hippostasin
- hK11
- Kallikrein 11
- kallikrein-related peptidase 11
- KLK11
- MGC33060
- PRSS20kallikrein-11
- Serine protease 20
- TLSPhippostasin
- Trypsin-like protease
Background
The human tissue kallikrein (KLK) gene family contains 15 members that play important roles in cancer. Notably, kallikrein-1, also known as tissue kallikrein, cleaves kininogen to release the vasoactive kinin peptide, bradykinin or lysyl-bradykinin. Kallikrein-3, called prostate specific antigen (PSA), is an established tumor marker that aids in the diagnosis, staging, and follow up of prostate cancer. Kallikrein-4 is specifically expressed in the prostate and over-expressed in prostate cancer. Kallikrein-5 is widely expressed but found at high levels in skin, breast, brain and testis; over-expression is an indicator of poor prognosis in ovarian cancer. Kallikrein-8 is expressed in the brain and is a novel marker of ovarian and cervical cancer.
Human plasma kallikrein, a serine protease, is synthesized in the liver and circulates in the plasma bound to high molecular weight (HMW) kininogen or as a free zymogen. Once activated by its physiological activator, coagulation factor XII, it displays endopeptidase activity towards peptide bonds after arginine (preferred) and lysine. It cleaves HMW kininogen, its major physiological substrate, to release the potent vasodilator peptide bradykinin. It is also able to cleave a number of inactive precursor proteins to generate active products, such as plasminogen and prourokinase.